EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bacterial Lectin FimH and Its Aggregation Hot-Spots: An Alternative Strategy against Uropathogenic Escherichia coli

Georgia I Nasi iD, Konstantina I Georgakopoulou, Marilena K Theodoropoulou, Nikos C Papandreou iD, Evangelia D Chrysina, Paraskevi L Tsiolaki iD, Vassiliki A Iconomidou iD

Pharmaceutics · 22.03.2023 · 15 (3) · 1018

DOI: 10.3390/pharmaceutics15031018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 22.03.2023. Verfasst von Georgia I Nasi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cell Biology and Biophysics, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, 15701 Athens, Gree…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type I fimbriae are the main adhesive organelles of uropathogenic Escherichia coli (UPEC), consisting of four different subunits. Their component with the most important role in establishing bacterial infections is the FimH adhesin located at the fimbrial tip. This two-domain protein mediates adhesion to host epithelial cells through interaction with terminal mannoses on epithelial glycoproteins. Here, we propose that the amyloidogenic potential of FimH can be exploited for the development of therapeutic agents against Urinary Tract Infections (UTIs). Aggregation-prone regions (APRs) were identified via computational methods, and peptide-analogues corresponding to FimH lectin domain APRs were chemically synthesized and studied with the aid of both biophysical experimental techniques and molecular dynamic simulations. Our findings indicate that these peptide-analogues offer a promising set of antimicrobial candidate molecules since they can either interfere with the folding process of FimH or compete for the mannose-binding pocket.

Schlagwörter

Stichwörter der Autor:innen

FimHUPECUTIsaggregation-prone regionslectinpredictiontype I fimbriae

Autor:innen und Institutionen

  • Section of Cell Biology and Biophysics, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, 15701 Athens, Greece.
  • Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.

ORCID-Profile: Georgia I Nasi, Nikos C Papandreou, Paraskevi L Tsiolaki, Vassiliki A Iconomidou

Zitieren

APA

Nasi, G. I., Georgakopoulou, K. I., Theodoropoulou, M. K., Papandreou, N. C., Chrysina, E. D., Tsiolaki, P. L., & Iconomidou, V. A. (2023). Bacterial Lectin FimH and Its Aggregation Hot-Spots: An Alternative Strategy against Uropathogenic Escherichia coli. Pharmaceutics, 15(3), 1018. https://doi.org/10.3390/pharmaceutics15031018

Vancouver

Nasi GI, Georgakopoulou KI, Theodoropoulou MK, Papandreou NC, Chrysina ED, Tsiolaki PL, et al. Bacterial Lectin FimH and Its Aggregation Hot-Spots: An Alternative Strategy against Uropathogenic Escherichia coli. Pharmaceutics. 2023;15(3):1018. doi:10.3390/pharmaceutics15031018

BibTeX
@article{Nasi2023,
  author = {Nasi, Georgia I and Georgakopoulou, Konstantina I and Theodoropoulou, Marilena K and Papandreou, Nikos C and Chrysina, Evangelia D and Tsiolaki, Paraskevi L and Iconomidou, Vassiliki A},
  title = {Bacterial Lectin FimH and Its Aggregation Hot-Spots: An Alternative Strategy against Uropathogenic Escherichia coli},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {1018},
  doi = {10.3390/pharmaceutics15031018}
}
Kostenlos starten →